ProShare Advisors LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$73,971
+53.1%
15,475
+36.1%
0.00%
Q2 2023$48,314
-16.0%
11,368
+5.0%
0.00%
Q1 2023$57,507
-25.3%
10,830
-11.7%
0.00%
Q4 2022$77,012
-35.3%
12,263
+8.5%
0.00%
Q3 2022$119,000
+101.7%
11,300
+4.7%
0.00%
Q2 2022$59,000
-59.3%
10,793
-31.5%
0.00%
Q1 2022$145,000
-25.6%
15,766
+22.1%
0.00%
Q4 2021$195,00012,9100.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
View complete list of CARIBOU BIOSCIENCES INC shareholders